Concentra Group Holdings Parent, Inc.

NYSE:CON

Medical - Equipment & Services

Healthcare
$41.98 +0.53%

+$0.15 today

Market cap
$5.31B
Beta
0.82
P/E (TTM)
20.3
EPS (TTM)
$1.41
Dividend yield
0.88%
52W Low $18.55High $28.94

Volume 0.74M

Average 0.90M

CON Interest Expense

Cost of servicing the company's debt during the period.

Concentra Group Holdings Parent, Inc.NYSE: CON

Interest Expense · Q3 FY2026 · quarter ended Sep 2026

Interest expense declines year over year

Q3 FY2026 interest expense of $25.16M fell 12.3% year over year, behind the -0.5% change in trailing-twelve-month interest expense. Sequentially, it fell 2.2% from the prior quarter. Over 3 fiscal years it compounded at +51.2% a year.

Context

  • Interest expense amounted to 5.1% of revenue in FY2025, up 1.4 pp from a year earlier.
  • Interest expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -12.3% toward the trailing-twelve-month pace of -0.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$25.16M-2.2% QoQ
Last fiscal yearDec 2025
$109.29M+56.8% YoY
LTMSep 2026
$103.76M-0.5% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.3%——
1 year+56.8%——
3-year CAGR+51.2%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
109.29M USD
Year-over-year change
+56.8%
4-year CAGR
+36.1%

Interest Expense vs competitors

How CON compares with its peers on the latest reported figures

  • CON's LTM Sep 2026 interest expense of $103.76M is the 2nd highest of the 10 companies compared; the peer median is $30.59M.
  • Its year-over-year change of -0.5% is the 5th highest of 7, against a peer median of +5.9%.
  • Interest expense amounts to 4.4% of revenue for CON, versus a peer median of 2.1%.
CON Competitors Peer median
Interest Expense for CON and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$1.61B +8.7%+3.1%14.8%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$103.76M -0.5%+51.2%4.4%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$90M +28.6%+10.6%2.4%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$46.08M +3.1%-15.1%4.2%
ITGRInteger Holdings CorporationLTM Jul 2026$38.49M -23.6%+4.3%2.1%
HAEHaemonetics CorporationLTM Jun 2026$30.59M +51.6%+25.2%2.3%
ADUSAddus HomeCare CorporationLTM Jun 2026$9.94M -4.4%+2.5%0.7%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$0 ——0.0%
HCMHUTCHMED (China) LimitedLTM Jun 2025$0 —+63.9%0.0%
BEAMBeam Therapeutics Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding CON) $30.59M+5.9%+4.3%2.1%

Competitors are the stored peer set for CON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.73B1.72B1.84B1.9B2.16B
Cost of Revenue1.3B1.32B1.33B1.37B1.55B
Gross Profit427.98M408.19M512.43M527.98M613.09M
Gross Margin24.7%23.7%27.9%27.8%28.3%
Research & Development00000
Selling, General & Admin157.71M149.98M152M156.32M203.31M
Operating Expenses157.71M149.98M224.8M223.21M279.1M
Depreciation & Amortization82.21M73.67M73.05M67.18M75.82M
EBITDA389.63M330.2M360.16M368.27M408.93M
EBITDA Margin22.5%19.1%19.6%19.4%18.9%
Operating Income270.27M258.22M287.63M304.76M333.99M
Operating Margin15.6%15.0%15.6%16.0%15.4%
Interest Income00000
Interest Expense31.86M31.64M114.04M69.69M109.29M
Other Income / Expenses5.3M(33.32M)(45M)(73.37M)(110.17M)
Income Before Tax275.56M224.9M242.63M231.39M223.83M
Pre-Tax Margin15.9%13.0%13.2%12.2%10.3%
Income Tax Expense59.53M52.65M57.89M59.5M50.98M
Net Income208.88M166.73M179.95M166.54M166.42M
Net Margin12.1%9.7%9.8%8.8%7.7%
EPS (Basic)1.651.321.421.301.39
EPS (Diluted)1.651.321.421.301.30
Weighted Avg Shares126.59M126.59M126.59M128.13M126.65M
Weighted Avg Shares (Diluted)126.59M126.59M126.59M128.13M128.17M

Concentra Group Holdings Parent, Inc.

NYSE:CON

Intrinsic Alpha fair value

Locked

Current Price

$41.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.